Last reviewed · How we verify
NCT03873545
Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
trial testing Cryopreserved Osteochondral Allograft in Cartilage Injury in 34 participants. Participants enrolled and being followed up; not accepting new ones.
1 November 2028
Quick facts
| Lead sponsor | AlloSource |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 34 |
| Start date | 18 March 2019 |
| Primary completion | 1 November 2028 |
| Estimated completion | 30 December 2028 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Cryopreserved Osteochondral Allograft
Conditions studied
- Cartilage Injury — all drugs for Cartilage Injury →
- Cartilage Damage — all drugs for Cartilage Damage →
Sponsor
AlloSource
Who can join
Adults 18 to 60, any sex, with Cartilage Injury or Cartilage Damage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this clinical study is to evaluate the use of ProChondrix Cryopreserved Osteochondral Allograft to obtain evidence of effectiveness, defined as an improvement in physical function and pain, when used on a symptomatic cartilage defect on the femoral condyle or patella in a mechanically stable knee.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03873545
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cartilage Injury
Currently open trials in the same condition.
- NCT06082531 — Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis · NA · recruiting
- NCT04184687 — The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction · NA · recruiting
Other AlloSource trials
Trials by the same sponsor.
- NCT06853964 — Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction · active not recruiting
- NCT06512259 — AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction · recruiting
- NCT04301258 — ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03873545 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AlloSource
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03873545.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing